MedTech Innovator 2026 Accelerator

AMBER Tx General

Strategy Notes

The programme is a general medtech accelerator, not specifically focused on telepharmacy or LMIC prescription-drug access. The applicant's pre-revenue, pre-incorporation stage and Nigeria-only focus may be less competitive for a global cohort, though the regulatory expertise and platform build are relevant.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: $800,000 (shared among cohort)
Type: accelerator
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-28 OPEN → INELIGIBLE · The programme has already selected its 2026 cohort (announced May 27, 2026). The applicant is pre-revenue, pre-incorporation, and Nigeria-only focused, which does not match the global, post-revenue or mid-stage startup profile typically required. Additionally, the application deadline has passed.